₹1,678.95 9.05 (0.54%)
17-Jan-2025₹1,679.20 3.35 (0.20%)
17-Jan-2025BSE : 543245
NSE : GLAND
Sector : Health care
ISIN Code : INE068V01023
Last Updated: 17-Jan-2025
Market Cap (₹ Cr) | 27,669 |
Traded Value (₹ Cr) | 0.73 |
Volume (Shares) | 4,337 |
Face Value (₹) | 1 |
52-Week High (₹) | 2,220.95 |
52-Week High Date | 06-Aug-2024 |
52-Week Low (₹) | 1,590.00 |
52-Week Low Date | 24-Oct-2024 |
All Time High (₹) | 4,350.00 |
All Time High Date | 12-Aug-2021 |
All Time Low (₹) | 861.50 |
All Time Low Date | 22-May-2023 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 27,673 |
EPS - TTM (₹) [C] | 41.98 |
P/E Ratio (X) [C] | 40.00 |
Face Value (₹) | 1 |
Latest Dividend (%) | 2,000.00 |
Latest Dividend Date | 16-Aug-2024 |
Dividend Yield (%) | 1.19 |
Book Value Share (₹) [C] | 533.41 |
P/B Ratio (₹) [C] | 3.15 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
HDFC Mid-Cap Opportunities Fund (G) | 987.88 | 55,51,922 | 1.27 |
HDFC Mid-Cap Opportunities Fund (IDCW) | 987.88 | 55,51,922 | 1.27 |
HDFC Mid-Cap Opportunities Fund - Direct (IDCW) | 987.88 | 55,51,922 | 1.27 |
HDFC Mid-Cap Opportunities Fund - Direct (G) | 987.88 | 55,51,922 | 1.27 |
Mirae Asset Large & Midcap Fund - Regular (G) | 656.10 | 36,87,292 | 1.71 |
Mirae Asset Large & Midcap Fund - Regular (IDCW) | 656.10 | 36,87,292 | 1.71 |
Mirae Asset Large & Midcap Fund - Direct (IDCW) | 656.10 | 36,87,292 | 1.71 |
Mirae Asset Large & Midcap Fund - Direct (G) | 656.10 | 36,87,292 | 1.71 |
SBI Large & Midcap Fund (IDCW) | 516.01 | 29,00,000 | 1.76 |
SBI Large & Midcap Fund (G) | 516.01 | 29,00,000 | 1.76 |
Load more
Today's Low/High (₹) | 1,670.00 1,704.95 |
Week Low/High (₹) | 1,645.40 1,808.00 |
Month Low/High (₹) | 1,645.40 1,964.00 |
Year Low/High (₹) | 1,585.70 2,221.00 |
All time Low/High (₹) | 861.50 4,350.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -5.89% | -5.77% | -0.98 | -0.97% |
1 Month | -4.10% | -3.90% | -5.04 | -4.65% |
3 Month | 2.41% | 2.41% | -5.42 | -6.25% |
6 Month | -18.22% | -18.13% | -5.08 | -5.73% |
1 Year | -14.04% | -14.06% | 7.16 | 7.56% |
3 Year | -54.54% | -54.58% | 24.97 | 26.74% |
Chairman & Independent Directo : Yiu Kwan Stanley Lau
Managing Director & CEO : SRINIVAS SADU
Non-Exec & Non-Independent Dir : UDO JAHANNES VETTER
Independent Director : C S N Murthy
Independent Director : ESSAJI GOOLAM VAHANVATI
Independent Director : Naina Lal Kidwai
Non-Exec & Non-Independent Dir : Jia Ai (Allen) Zhang
Non Executive Director : Wenjie Zhang
Additional Director : Wei Huang
Registered Office: Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal,Hyderabad,Telangana-500043 Ph: 91-40-30510999
1. What's the Gland Pharma Ltd share price today?
Gland Pharma Ltd share price was Rs 1,678.95 at close on 17th Jan 2025. Gland Pharma Ltd share price was up by 0.54% over the previous closing price of Rs 1,669.90. Gland Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Gland Pharma Ltd stock?
The performance of the Gland Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Gland Pharma Ltd?
Gland Pharma Ltd has a market capitalisation of Rs 27,669 crore.
4. What is Gland Pharma Ltd's 52-week high/low share price?
The Gland Pharma Ltd’s 52-week high share price is Rs 2,220.95 and 52-week low share price is Rs 1,590.00.
5. Is the Gland Pharma Ltd profitable?
On a consolidated basis, Gland Pharma Ltd reported a profit of Rs 281.71 crore on a total income of Rs 1,120.79 crore for the quarter ended 2024. For the year ended Sep 2024, Gland Pharma Ltd had posted a profit of Rs 163.53 crore on a total income of Rs 1,465.49 crore.
6. Which are Gland Pharma Ltd’s peers in the Health care sector?
Gland Pharma Ltd’s top 5 peers in the Health care sector are Glaxosmi. Pharma, Laurus Labs, Piramal Pharma, Gland Pharma, Suven Pharma, J B Chemicals &, Emcure Pharma.
7. Who owns how much in Gland Pharma Ltd?
Key changes to the Gland Pharma Ltd shareholding are as follows: